TNFα antagonist upregulates interleukin-6 in rats with hypertensive heart failure

International Journal of Cardiology

Volumn 130, Issue 1, 2008, Pages 64-68

  Haugen, Espen ^a   Scharin Täng, Margareta ^a   Isic, Azra ^a   Andersson, Bert ^a   Fu, Michael ^a,b  

^a Institute of Medicine   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac remodeling; Heart failure; Hypertension; Interleukin 6; Tumor necrosis factor antagonist

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; ETANERCEPT; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HEART WEIGHT; HYPERTENSION; INOTROPISM; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; WISTAR KYOTO RAT; ANIMAL; BIOSYNTHESIS; CHRONIC DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HEART FAILURE; HYPERTENSION; IMMUNOGLOBULIN G; INTERLEUKIN-6; MALE; RATS; RATS, INBRED SHR; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VENTRICULAR REMODELING;

EID: 51849108975     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.08.047     Document Type: Article

References (19)

1. Mann D.L. Inflammatory mediators and the failing: heart past present and the foreseeable future. Circ Res 91 (2002) 988-998
2. Tracey K.J., Beutler B., Lowry S.F., et al. Shock and tissue injury induced by recombinant human cachectin. Science 234 (1986) 470-474
3. Natanson C., Eichenholz P.W., Danner R.L., et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169 (1989) 823-832
4. Pagani F.D., Baker L.S., Hsi C., Knox M., Fink M.P., and Visner M.S. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 90 (1992) 389-398
5. Franco F., Thomas G.D., Giroir B.P., Bryant D., Bullock M.C., Chwialkowski M.C., Victor R.G., and Peshock R.M. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 99 (1999) 448-454
6. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
7. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST). Circulation 103 (2001) 2055-2059
8. TorreAmione G. Immune activation in chronic heart failure. Am J Cardiol 95 (2005) 3-8
9. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
10. Bozkurt B., Torre-Amione G., Warren M.S., et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 103 (2001) 1044-1047
11. Deswal A., Bozkurt B., Seta Y., et al. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99 (1999) 3224-3226
12. Anker S.D., and Coats A.J. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86 (2002) 123-130
13. Chung E.S., Packer M., Lo K.H., Fasanmade A.A., and Willerson J.T. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107 (2003) 3133-3140
14. Mann D.L., McMurray J.J., Packer M., et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109 (2004) 1594-1602
15. Guidelines for diagnosis and treatment of chronic heart failure by European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
16. Scharin Täng M, Haugen E, Isic A, Fu LXM, Andersson B. Influence of age, hypertension, and diabetes on cardiac reserve in a rat model. J Am Soc Echo in press.
17. Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ Res 95 (2004) 1140-1153
18. Yu X.W., Liu M.Y., Kennedy R.H., and Liu S.J. Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes. J Physiol 566 Pt 2 (2005) 341-353
19. Bellahcene M., Jacquet S., Cao X.B., et al. Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol 48 3 (2006) 545-555